Intravitreal ranibizumab for diabetic macular oedema in previously vitrectomized eyes

ConclusionIntravitreal ranibizumab can be effective in previously vitrectomized eyes with diabetic macular oedema. However, the response is variable and should be carefully monitored.

Source: Acta Ophthalmologica - July 29, 2016 Category: Opthalmology Authors: Caroline Schmidt Laugesen, Christoffer Ostri, Troels Brynskov, Henrik Lund ‐Andersen, Michael Larsen, Henrik Vorum, Torben L. Sørensen Tags: Original Article Source Type: research